| Upcoming events on ADAMIS PHARMACEUTICALS CORPORATION |
|
| 04/01/21 | | FY 2020 Earnings Release (Projected) |
| 05/07/21 | | Q1 2021 Earnings Release (Projected) |
| 08/06/21 | | Interim 2021 Earnings Release (Projected) |
| 11/15/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on ADAMIS PHARMACEUTICALS CORPORATION |
|
| 11/09/20 | 05:00pm | | Q3 2020 Earnings Call |
| 11/09/20 | 04:00pm | | Q3 2020 Earnings Release |
| 09/03/20 | 01:00pm | | Annual General Meeting |
| 08/20/20 | 04:30pm | | Interim 2020 Earnings Call |
|
| Upcoming sector events for ADAMIS PHARMACEUTICALS CORPORATION |
|
|
| |
|
| Past sector events for ADAMIS PHARMACEUTICALS CORPORATION |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread |
| 6,47
6,43
0,73% | 13,1
14,4
-9,2% | 15,1
16,3
-7,4% | 22,1
22,6
-2,1% |
18,3
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
| -22,7
-25,0
9,3% | -21,6
-18,4
-18% | -36,4
-33,3
-9,1% |
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -13,9
-13,9
0,27% | -25,2
-25,4
0,78% | -24,8
-21,5
-15% | -39,5
-35,0
-13% | -29,0
-27,6
-5,1% |
-33,5
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -13,6
-12,8
-5,7% | -24,0
-24,8
3,2% | -25,9
-22,3
-16% | -39,4
-34,3
-15% | -29,3
-27,5
-6,4% |
-33,9
|
Net income
M $ |
Released
Forecast
Spread | -13,6
-12,8
-5,7% | -20,8
-24,8
16% | -25,5
-22,6
-13% | -39,0
-34,3
-14% | -29,3
-27,5
-6,5% |
-33,9
|
EPS
$ |
Released
Forecast
Spread | -1,02
-0,97
-5,2% | -1,19
-1,48
20% | -0,90
-0,81
-12% | -1,00
-0,88
-14% | -0,55
-0,53
-4,8% |
-0,45
| | Announcement Date | 03/23/2016 | 03/30/2017 | 03/16/2018 | 03/15/2019 | 03/30/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q2 | 2020 Q3 | 2020 Q1 (e) | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 3,92
3,98
-1,6% | 3,80
4,73
-20% | 4,15
5,47
-24% | 4,91
5,79
-15% | 5,80
5,84
-0,69% | 5,90
5,93
-0,37% | 5,54
6,00
-7,7% | 3,93
5,30
-26% | 4,30
4,72
-8,8% |
5,58
|
4,61
|
5,69
|
5,94
|
6,43
|
6,68
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -8,90
-5,01
-77% | -8,13
-8,84
8,0% | -12,5
-9,47
-32% | -8,15
-7,33
-11% | -7,09
-6,22
-14% |
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -9,67
-6,21
-56% | -8,91
-7,11
-25% | -13,3
-8,85
-50% | -8,94
-7,95
-12% | -7,75
-6,10
-27% | -7,01
-5,39
-30% | -5,34
-3,91
-36% | -11,2
-6,04
-86% | -6,84
-6,46
-5,8% |
-5,04
|
-5,13
|
|
|
|
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -9,70
-6,22
-56% | -8,88
-6,32
-40% | -13,2
-8,10
-63% | -8,89
-7,91
-12% | -7,74
-6,08
-27% | -7,00
-5,39
-30% | -5,68
-3,91
-45% | -11,3
-6,04
-86% | -7,49
-6,48
-16% |
-5,04
|
-5,15
|
|
|
|
|
Net income
M $ |
Released
Forecast
Spread | -9,70
-6,22
-56% | -8,88
-6,32
-40% | -12,8
-8,10
-58% | -8,89
-7,91
-12% | -7,74
-6,08
-27% | -7,00
-5,39
-30% | -5,68
-3,91
-45% | -11,3
-6,04
-86% | -7,49
-6,48
-16% |
-5,04
|
-5,15
|
|
|
|
|
EPS
$ |
Released
Forecast
Spread | -0,29
-0,19
-55% | -0,21
-0,15
-43% | -0,28
-0,17
-65% | -0,19
-0,17
-15% | -0,16
-0,13
-23% | -0,12
-0,10
-26% | -0,08
-0,07
-23% | -0,15
-0,08
-88% | -0,10
-0,09
-18% |
-0,07
|
-0,06
|
|
|
|
| | Announcement Date | 08/09/2018 | 11/09/2018 | 03/15/2019 | 05/09/2019 | 08/08/2019 | 11/12/2019 | 03/30/2020 | 08/17/2020 | 11/09/2020 | | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
